Modulation of HepG2 cell net apolipoprotein B secretion by the citrus polymethoxyflavone, tangeretin

被引:80
|
作者
Kurowska, EM
Manthey, JA
Casaschi, A
Theriault, AG
机构
[1] KGK Synergize Inc, Res & Dev Div, London, ON N6A 5R8, Canada
[2] USDA ARS, S Atlantic Area, Citrus & Subtrop Prod Lab, Winter Haven, FL 33881 USA
[3] Univ Hawaii Manoa, John A Burns Sch Med, Div Med Technol, Honolulu, HI 96822 USA
关键词
D O I
10.1007/s11745-004-1212-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of the present study was to examine the role of tangeretin, a polymethoxylated flavone from citrus fruits, on the regulation of apolipoprotein B (apoB) and lipid metabolism in the human hepatoma cell-line HepG2. The marked reduction in apoB secretion observed in cells incubated with 72.8 muM tangeretin was rapid, apoB-specific, and partly reversible. The reduction also was observed under lipid-rich conditions and found to be insensitive to proteasomal degradation of nascent apoB. We followed our study by examining lipid synthesis and mass. A 24-h exposure of cells to 72.8 muM tangeretin decreased intracellular synthesis of cholesteryl esters, free cholesterol, and TAG by 82, 45, and 64%, respectively; tangeretin also reduced the mass of cellular TAG by 37%. The tangeretin-induced suppression of TAG synthesis and mass were associated with decreased activities of DAG acyltransferase (up to -39.0 +/- 3.0% vs. control) and microsomal triglyceride transfer protein (up to -35.5 +/- 2.5% vs. control). Tangeretin was also found to activate the peroxisome proliferator-activated receptor, a transcription actor with a positive regulatory impact on FA oxidation and TAG availability (up to 36% increase vs. control). The data suggest that tangeretin modulates apoB-containing lipoprotein metabolism through multiple mechanisms.
引用
收藏
页码:143 / 151
页数:9
相关论文
共 50 条
  • [1] ACTH decreases the expression and secretion of apolipoprotein B in HepG2 cell cultures
    Xu, N
    Ekstrom, U
    Nilsson-Ehle, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) : 38680 - 38684
  • [2] Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin
    Borradaile, NM
    Carroll, KK
    Kurowska, EM
    LIPIDS, 1999, 34 (06) : 591 - 598
  • [3] Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells
    Mohammadi, A
    Macri, J
    Newton, R
    Romain, T
    Dulay, D
    Adeli, K
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (05) : 783 - 793
  • [4] Inhibition of apolipoprotein B and triglyceride secretion in human hepatoma cells (HepG2)
    Haghpassand, M
    Wilder, D
    Moberly, JB
    JOURNAL OF LIPID RESEARCH, 1996, 37 (07) : 1468 - 1480
  • [5] The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells
    Casaschi, A
    Maiyoh, GK
    Rubio, BK
    Li, RW
    Adeli, K
    Theriault, AG
    JOURNAL OF NUTRITION, 2004, 134 (06): : 1340 - 1346
  • [6] REGULATION OF APOLIPOPROTEIN SECRETION BY HUMAN HEPATOMA, HEPG2
    CRAIG, WY
    COOPER, AD
    ARTERIOSCLEROSIS, 1986, 6 (05): : A536 - A537
  • [7] Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation
    Borradaile, NM
    de Dreu, LE
    Huff, MW
    DIABETES, 2003, 52 (10) : 2554 - 2561
  • [8] Demonstration of biphasic effects of docosahexaenoic acid on apolipoprotein B secretion in HepG2 cells
    Wu, XJ
    Shang, AM
    Jiang, HS
    Ginsberg, HN
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) : 3347 - 3355
  • [9] Taurine reduces the secretion of apolipoprotein B100 and lipids in HepG2 cells
    Yanagita, Teruyoshi
    Han, Seo-Young
    Hu, Ying
    Nagao, Koji
    Kitajima, Hideaki
    Murakami, Shigeru
    LIPIDS IN HEALTH AND DISEASE, 2008, 7 (1)
  • [10] Taurine reduces the secretion of apolipoprotein B100 and lipids in HepG2 cells
    Teruyoshi Yanagita
    Seo-Young Han
    Ying Hu
    Koji Nagao
    Hideaki Kitajima
    Shigeru Murakami
    Lipids in Health and Disease, 7